Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acids, Omega-6 | 3 | 2017 | 22 | 0.660 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2023 | 80 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1457 | 0.340 |
Why?
|
| Arachidonic Acid | 3 | 2019 | 52 | 0.310 |
Why?
|
| Trans Fatty Acids | 2 | 2022 | 12 | 0.290 |
Why?
|
| Linoleic Acid | 2 | 2019 | 20 | 0.280 |
Why?
|
| Fatty Acids | 3 | 2022 | 374 | 0.240 |
Why?
|
| Gallbladder Neoplasms | 1 | 2026 | 15 | 0.240 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2026 | 23 | 0.230 |
Why?
|
| Cholangiocarcinoma | 1 | 2026 | 125 | 0.210 |
Why?
|
| Bile Duct Neoplasms | 1 | 2026 | 134 | 0.210 |
Why?
|
| Genetic Loci | 2 | 2017 | 353 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2026 | 356 | 0.180 |
Why?
|
| alpha-Linolenic Acid | 2 | 2023 | 15 | 0.170 |
Why?
|
| Mortality, Premature | 1 | 2021 | 13 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2026 | 814 | 0.170 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 67 | 0.170 |
Why?
|
| Docosahexaenoic Acids | 2 | 2016 | 67 | 0.140 |
Why?
|
| Cause of Death | 1 | 2021 | 503 | 0.140 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2018 | 3 | 0.140 |
Why?
|
| Biomarkers | 5 | 2022 | 3367 | 0.140 |
Why?
|
| Fatty Acid Desaturases | 2 | 2015 | 12 | 0.140 |
Why?
|
| Myosins | 1 | 2018 | 41 | 0.140 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 143 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2023 | 6424 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2019 | 276 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2019 | 183 | 0.130 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 48 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 241 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2026 | 1546 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 484 | 0.110 |
Why?
|
| Carboxy-Lyases | 1 | 2015 | 16 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2015 | 63 | 0.110 |
Why?
|
| Risk Factors | 5 | 2023 | 11013 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2022 | 5049 | 0.110 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1046 | 0.110 |
Why?
|
| Phospholipids | 1 | 2014 | 100 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 850 | 0.100 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 1829 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2016 | 626 | 0.090 |
Why?
|
| Incidence | 2 | 2017 | 3338 | 0.090 |
Why?
|
| Mutation | 1 | 2026 | 6064 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 818 | 0.080 |
Why?
|
| Protective Factors | 2 | 2021 | 90 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 496 | 0.070 |
Why?
|
| Diet | 1 | 2015 | 1113 | 0.070 |
Why?
|
| Humans | 13 | 2026 | 130534 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1238 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 2827 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 2110 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2026 | 777 | 0.050 |
Why?
|
| Adult | 3 | 2022 | 31114 | 0.050 |
Why?
|
| Middle Aged | 5 | 2023 | 28408 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2026 | 709 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2026 | 889 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2026 | 760 | 0.040 |
Why?
|
| Recommended Dietary Allowances | 1 | 2019 | 21 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2019 | 84 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 103 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2018 | 16 | 0.030 |
Why?
|
| Lactase | 1 | 2018 | 42 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 278 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6771 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 20885 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 219 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 2015 | 19 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2015 | 74 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 110 | 0.030 |
Why?
|
| Male | 5 | 2021 | 64613 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2015 | 82 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2014 | 67 | 0.030 |
Why?
|
| Female | 5 | 2021 | 70545 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2014 | 137 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 148 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1208 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 729 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5187 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 618 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3685 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1690 | 0.020 |
Why?
|
| Genomics | 1 | 2014 | 1620 | 0.010 |
Why?
|
| Animals | 1 | 2026 | 33726 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 20889 | 0.010 |
Why?
|